12:00 AM
 | 
Dec 04, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Amlexanox: Phase IV data; marketed

In a Phase IV European trial, amlexanox paste prevented ulcer formation when applied at the first sign or symptom of the disease, as detected by thermographic evaluation of the mouth. The number...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >